Beneficient Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Beneficient stock issued during period, value, new issues for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Beneficient stock issued during period, value, new issues for the quarter ending 2024-12-31 was $0.00.
- Beneficient stock issued during period, value, new issues for the quarter ending 2024-09-30 was $673.00K.
- Beneficient stock issued during period, value, new issues for the quarter ending 2024-03-31 was $1.48M.
- Beneficient stock issued during period, value, new issues for fiscal 2025 was $673.00K.
- Beneficient stock issued during period, value, new issues for fiscal 2024 was -$4.29M, a 121.34% decline from fiscal 2023.
- Beneficient stock issued during period, value, new issues for fiscal 2023 was $20.10M.
- Beneficient stock issued during period, value, new issues for fiscal 2021 was $207.39M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-30 | $673.00K 10-K · filed 2026-06-30 |
| 2024-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | |
| 2024-09-30 | $673.00K 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | -$4.29M 10-K · filed 2025-09-29 |
| 2023-12-31 | -$1.48M 10-Q · filed 2025-02-14 | -$5.77M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-14 | -$4.29M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$4.29M 10-Q · filed 2024-08-14 | $15.81M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-09 | $20.10M 10-K · filed 2024-07-09 |
| 2022-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-14 | |
| 2022-09-30 | $20.10M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $207.39M 10-K · filed 2023-07-13 |